FDA Commissioner Califf to Receive the Ellen V. Sigal Advocacy Leadership Award Congresswoman Dingell to Receive the Marlene A. Malek Public Service Award Washington, DC – August 15, 2023 – Friends of Cancer Research (Friends) is proud to announce our 2023 Cancer Leadership Awards honorees: Commissioner of the U.S. Food and Drug Administration, Dr. Robert Califf,…
Friends of Cancer Research (Friends) is excited to present data from three current projects at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. These findings are catalyzing meaningful improvements in oncology drug development and informing regulatory policy and patient care. Abstract Details Changes in ctDNA levels as an early indicator of outcomes in…
Friends of Cancer Research (Friends) thanks President Joe Biden for nominating Dr. Monica Bertagnolli as the Director of the National Institute of Health (NIH). “At this critical time for innovation at the NIH, Dr. Bertagnolli will be the visionary leader we need,” said Ellen Sigal, Chair & Founder of Friends of Cancer Research. As the…
Friends of Cancer Research (Friends) commends the National Cancer Institute (NCI) and their Director Dr. Monica Bertagnolli, for the recently announced National Cancer Plan. This critical and innovative plan provides a framework for collaboration and partnership across agencies seeking to improve the lives of millions of cancer patients and families. “Dr. Bertagnolli and the Biden…
Friends of Cancer Research (Friends) applauds Larry Bucshon (R-IN) and Diana DeGette (D-CO) for their leadership introducing the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act). The VALID Act would resolve longstanding uncertainty associated with the regulation and use of diagnostic tests that play a critical role in patient care.…
Friends of Cancer Research (Friends) is excited to announce the addition of City of Hope physician executive Edward S. Kim, M.D., M.B.A., FACP, FASCO, to its Board of Directors. Dr. Kim, recognized as one of the top cancer experts in the nation, is Physician-in-Chief and Senior Vice President, City of Hope Orange County, Construction Industries Alliance…
A new manuscript by Friends of Cancer Research (Friends) published today in JCO Clinical Cancer Informatics, details a framework to align electronic patient reported outcome (ePRO) data capture across ePRO tools to assess the value of ePROs for improving patient outcomes. This work can help expedite efforts to generate robust real-world data (RWD). PROs are…
Friends of Cancer Research (Friends) is pleased to support the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) and urges Congress to include this as part of the 2023 omnibus appropriations bill. The VALID Act would resolve longstanding uncertainty associated with the regulation and use of diagnostic tests that play…
Friends of Cancer Research (Friends) is excited to announce new data from the Homologous Recombination Deficiency (HRD) Harmonization Project shared this weekend at The Association of Molecular Pathology Annual Meeting. The HRD Harmonization Project is a unique research partnership focused on understanding the variability in HRD assays and developing strategies to align methodology for measuring…
A new manuscript by Friends of Cancer Research (Friends) published in JCO Precision Oncology, finds strong associations between reductions in circulating tumor DNA (ctDNA) levels from on treatment liquid biopsies with improved overall survival and progression-free survival in non-small cell lung cancer (NSCLC). This manuscript highlights results that provide the initial basis of Friends’ ongoing…
